Bruker, Premier Biosoft Enter Reselling Agreement for SimLipid, SimMet Software | GenomeWeb

NEW YORK(GenomeWeb) – Premier Biosoft and Bruker said today that they have entered a reselling agreement under which Bruker will co-market and resell Premier's SimLipid and SimMet informatics software. 

SimLipid and SimMet are intended for mass spec-based analysis of, respectively, lipids and metabolites and facilitate automated LC-MS and MS/MS data processing workflows and identification and quantitation of these analytes, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.